# Phase 5 final hardening findings

A second source audit identified additional data-integrity and safety gaps after the initial Phase 5 feature-complete review. All findings below are now corrected in source with targeted regression coverage where practical. Executable verification remains separate.

## Resolved findings

1. **Complete archive omission — resolved.** The full archive is now schema v2 and includes Phase 5 preventive/platform data. Legacy v1 archives still import. Import rollback and delete-all now include the Phase 5 store.
2. **Preventive provenance/completion — resolved.** The Platform UI supports manual versus clinician/public-health provenance, optional provider/source names and notes. Reminder completion is atomic, preserves provenance, and creates a next reminder only from an explicitly entered repeat interval. Enable/disable is reversible.
3. **Explicit external share contract — resolved.** `shareIntegrationBundle()` requires a positive confirmation argument and reconstructs a new payload containing only declared scopes before handing data to a connected host. The UI separately confirms destination plus scopes.
4. **Validation-claim evidence quality — resolved in the software gate.** A validated claim now requires complete external-study evidence and a distinct explicitly independent replication record, with unique IDs, valid reviewed timestamps, populated population/protocol/outcome data and distinct references. This does not replace real evidence-quality review.
5. **Ambiguous regulatory profiles — resolved.** A feature with no declared high-risk flags no longer defaults to wellness scope unless wellness intended use is explicitly declared. Ambiguous scope escalates for specialist review.
6. **UI destructive-error handling — resolved.** Preventive deletion/completion/state-change errors are caught and surfaced in-app.
7. **Portable archive wording — resolved.** Complete export/import/delete UI explicitly includes Phase 5 platform/preventive data.
8. **Partially corrupt local storage overwrite risk — resolved.** Invalid entries remain visible as a storage warning and normal mutations are blocked rather than rewriting the store and silently dropping unreadable records. Explicit replacement/deletion remains possible.
9. **Preventive recurrence/date edge cases — resolved.** Calendar dates are validated strictly, impossible dates are rejected, and month-end recurrence is UTC-stable and clamped.
10. **Clinician source conflation — resolved.** Connected metric rows in clinician exports remain separated by source ID instead of silently combining overlapping providers.

## Remaining evidence, not source defects

- TypeScript, unit-test, production-build and PWA execution on an eligible runner.
- Representative browser/accessibility/offline QA.
- Synthetic clinician-export review.
- Live integration-host QA if a host is connected.
- Real external validation and independent replication before any capability model can truthfully claim validated intended use.
- Specialist regulatory/legal/clinical review for any escalated feature profile.

The final independent whole-repository review prompt is saved at `docs/end-to-end-code-review-agent-prompt.md`.